A case of advanced esophageal cancer with extensive lymph node metastases successfully treated with multimodal therapy

Kaori Shigemitsu, Yoshio Naomoto, Yasuhiro Shirakawa, Minou Haisa, Mehmet Gunduz, Noriaki Tanaka

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Advanced esophageal cancer patients with extensive lymph node metastases show extremely poor prognosis and the long-term outcome is poorer with the involvement of more lymph nodes. We report here a long-surviving case of advanced esophageal cancer with histologically 34 lymph node metastases, in which surgical resection with three-field lymphadenectomy followed by adjuvant chemotherapy and radiotherapy was performed. A 53-year-old male was diagnosed as advanced middle esophageal cancer with multiple regional lymph node metastases such as paraesophageal, pretracheal, tracheobronchial and bifurcational lymph nodes and three intramural metastatic lesions. Subtotal esophagectomy with three-field lymphadenectomy was performed for the tumor. Histopathologically, the tumor was poorly differentiated squamous cell carcinoma and 34 lymph nodes including ligamentum arteriosum lymph nodes and pretracheal lymph nodes were proved to be metastatic. Numerous tumor cells were found in the lymphatic vessels near the metastatic lymph nodes. Chemotherapy [3000 mg of 5-fluorouracil (5-FU), 50 mg of cisplatin (CDDP) and 30 mg of methotrexate (MTX)] was administered in two courses, followed by radiation therapy (field size 21 × 20 cm in mediastinum, 10 MV X-rays, 2 Gy/fr, 5 fr/week, total 46 Gy). Subsequently, 1000 mg of 5-FU and 200 mg of CDDP were administered every 3-4 months without any significant toxicities. The patient has been alive and well without recurrence for 5 years following operation. For treatment of advanced esophageal cancer with extensive lymph node metastases, a wide resection of the tumor and regional lymph nodes should be performed, followed by adjuvant chemotherapy and radiotherapy.

Original languageEnglish
Pages (from-to)310-314
Number of pages5
JournalJapanese Journal of Clinical Oncology
Volume32
Issue number8
DOIs
Publication statusPublished - Aug 1 2002

Fingerprint

Esophageal Neoplasms
Lymph Nodes
Neoplasm Metastasis
Therapeutics
Adjuvant Radiotherapy
Adjuvant Chemotherapy
Lymph Node Excision
Fluorouracil
Neoplasms
Lymphatic Vessels
Esophagectomy
Mediastinum
Methotrexate
Cisplatin
Squamous Cell Carcinoma
Radiotherapy
X-Rays
Recurrence
Drug Therapy

Keywords

  • Adjuvant therapy
  • Esophageal cancer
  • Lymph node metastasis
  • Multimodal therapy

ASJC Scopus subject areas

  • Oncology

Cite this

A case of advanced esophageal cancer with extensive lymph node metastases successfully treated with multimodal therapy. / Shigemitsu, Kaori; Naomoto, Yoshio; Shirakawa, Yasuhiro; Haisa, Minou; Gunduz, Mehmet; Tanaka, Noriaki.

In: Japanese Journal of Clinical Oncology, Vol. 32, No. 8, 01.08.2002, p. 310-314.

Research output: Contribution to journalArticle

Shigemitsu, Kaori ; Naomoto, Yoshio ; Shirakawa, Yasuhiro ; Haisa, Minou ; Gunduz, Mehmet ; Tanaka, Noriaki. / A case of advanced esophageal cancer with extensive lymph node metastases successfully treated with multimodal therapy. In: Japanese Journal of Clinical Oncology. 2002 ; Vol. 32, No. 8. pp. 310-314.
@article{59e0fce4329447dab472a2d7c7855773,
title = "A case of advanced esophageal cancer with extensive lymph node metastases successfully treated with multimodal therapy",
abstract = "Advanced esophageal cancer patients with extensive lymph node metastases show extremely poor prognosis and the long-term outcome is poorer with the involvement of more lymph nodes. We report here a long-surviving case of advanced esophageal cancer with histologically 34 lymph node metastases, in which surgical resection with three-field lymphadenectomy followed by adjuvant chemotherapy and radiotherapy was performed. A 53-year-old male was diagnosed as advanced middle esophageal cancer with multiple regional lymph node metastases such as paraesophageal, pretracheal, tracheobronchial and bifurcational lymph nodes and three intramural metastatic lesions. Subtotal esophagectomy with three-field lymphadenectomy was performed for the tumor. Histopathologically, the tumor was poorly differentiated squamous cell carcinoma and 34 lymph nodes including ligamentum arteriosum lymph nodes and pretracheal lymph nodes were proved to be metastatic. Numerous tumor cells were found in the lymphatic vessels near the metastatic lymph nodes. Chemotherapy [3000 mg of 5-fluorouracil (5-FU), 50 mg of cisplatin (CDDP) and 30 mg of methotrexate (MTX)] was administered in two courses, followed by radiation therapy (field size 21 × 20 cm in mediastinum, 10 MV X-rays, 2 Gy/fr, 5 fr/week, total 46 Gy). Subsequently, 1000 mg of 5-FU and 200 mg of CDDP were administered every 3-4 months without any significant toxicities. The patient has been alive and well without recurrence for 5 years following operation. For treatment of advanced esophageal cancer with extensive lymph node metastases, a wide resection of the tumor and regional lymph nodes should be performed, followed by adjuvant chemotherapy and radiotherapy.",
keywords = "Adjuvant therapy, Esophageal cancer, Lymph node metastasis, Multimodal therapy",
author = "Kaori Shigemitsu and Yoshio Naomoto and Yasuhiro Shirakawa and Minou Haisa and Mehmet Gunduz and Noriaki Tanaka",
year = "2002",
month = "8",
day = "1",
doi = "10.1093/jjco/hyf067",
language = "English",
volume = "32",
pages = "310--314",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - A case of advanced esophageal cancer with extensive lymph node metastases successfully treated with multimodal therapy

AU - Shigemitsu, Kaori

AU - Naomoto, Yoshio

AU - Shirakawa, Yasuhiro

AU - Haisa, Minou

AU - Gunduz, Mehmet

AU - Tanaka, Noriaki

PY - 2002/8/1

Y1 - 2002/8/1

N2 - Advanced esophageal cancer patients with extensive lymph node metastases show extremely poor prognosis and the long-term outcome is poorer with the involvement of more lymph nodes. We report here a long-surviving case of advanced esophageal cancer with histologically 34 lymph node metastases, in which surgical resection with three-field lymphadenectomy followed by adjuvant chemotherapy and radiotherapy was performed. A 53-year-old male was diagnosed as advanced middle esophageal cancer with multiple regional lymph node metastases such as paraesophageal, pretracheal, tracheobronchial and bifurcational lymph nodes and three intramural metastatic lesions. Subtotal esophagectomy with three-field lymphadenectomy was performed for the tumor. Histopathologically, the tumor was poorly differentiated squamous cell carcinoma and 34 lymph nodes including ligamentum arteriosum lymph nodes and pretracheal lymph nodes were proved to be metastatic. Numerous tumor cells were found in the lymphatic vessels near the metastatic lymph nodes. Chemotherapy [3000 mg of 5-fluorouracil (5-FU), 50 mg of cisplatin (CDDP) and 30 mg of methotrexate (MTX)] was administered in two courses, followed by radiation therapy (field size 21 × 20 cm in mediastinum, 10 MV X-rays, 2 Gy/fr, 5 fr/week, total 46 Gy). Subsequently, 1000 mg of 5-FU and 200 mg of CDDP were administered every 3-4 months without any significant toxicities. The patient has been alive and well without recurrence for 5 years following operation. For treatment of advanced esophageal cancer with extensive lymph node metastases, a wide resection of the tumor and regional lymph nodes should be performed, followed by adjuvant chemotherapy and radiotherapy.

AB - Advanced esophageal cancer patients with extensive lymph node metastases show extremely poor prognosis and the long-term outcome is poorer with the involvement of more lymph nodes. We report here a long-surviving case of advanced esophageal cancer with histologically 34 lymph node metastases, in which surgical resection with three-field lymphadenectomy followed by adjuvant chemotherapy and radiotherapy was performed. A 53-year-old male was diagnosed as advanced middle esophageal cancer with multiple regional lymph node metastases such as paraesophageal, pretracheal, tracheobronchial and bifurcational lymph nodes and three intramural metastatic lesions. Subtotal esophagectomy with three-field lymphadenectomy was performed for the tumor. Histopathologically, the tumor was poorly differentiated squamous cell carcinoma and 34 lymph nodes including ligamentum arteriosum lymph nodes and pretracheal lymph nodes were proved to be metastatic. Numerous tumor cells were found in the lymphatic vessels near the metastatic lymph nodes. Chemotherapy [3000 mg of 5-fluorouracil (5-FU), 50 mg of cisplatin (CDDP) and 30 mg of methotrexate (MTX)] was administered in two courses, followed by radiation therapy (field size 21 × 20 cm in mediastinum, 10 MV X-rays, 2 Gy/fr, 5 fr/week, total 46 Gy). Subsequently, 1000 mg of 5-FU and 200 mg of CDDP were administered every 3-4 months without any significant toxicities. The patient has been alive and well without recurrence for 5 years following operation. For treatment of advanced esophageal cancer with extensive lymph node metastases, a wide resection of the tumor and regional lymph nodes should be performed, followed by adjuvant chemotherapy and radiotherapy.

KW - Adjuvant therapy

KW - Esophageal cancer

KW - Lymph node metastasis

KW - Multimodal therapy

UR - http://www.scopus.com/inward/record.url?scp=0036688840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036688840&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyf067

DO - 10.1093/jjco/hyf067

M3 - Article

C2 - 12411570

AN - SCOPUS:0036688840

VL - 32

SP - 310

EP - 314

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 8

ER -